This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción DNL
Diurnal Group plc operates as a specialty pharma company worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Competidores de Diurnal Group plc
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.27 |
| 52 Week High | UK£0.68 |
| 52 Week Low | UK£0.095 |
| Beta | 0.35 |
| 1 Month Change | 0.55% |
| 3 Month Change | 180.00% |
| 1 Year Change | -54.65% |
| 3 Year Change | -14.69% |
| 5 Year Change | -80.84% |
| Change since IPO | -82.16% |
Noticias y actualizaciones recientes
Recent updates
Diurnal Group (LON:DNL) Will Have To Spend Its Cash Wisely
Aug 13
Shareholders May Not Be So Generous With Diurnal Group plc's (LON:DNL) CEO Compensation And Here's Why
Nov 13Companies Like Diurnal Group (LON:DNL) Can Afford To Invest In Growth
Feb 25What Can We Learn About Diurnal Group's (LON:DNL) CEO Compensation?
Feb 04Diurnal Group plc (LON:DNL): When Will It Breakeven?
Jan 14Diurnal Group (LON:DNL) Shareholders Have Enjoyed A 88% Share Price Gain
Dec 25Estimating The Fair Value Of Diurnal Group plc (LON:DNL)
Dec 02Rentabilidad de los accionistas
| DNL | GB Biotechs | Mercado GB | |
|---|---|---|---|
| 7D | 0% | 3.9% | 0.7% |
| 1Y | -54.7% | -26.7% | 3.0% |
Rentabilidad vs. Industria: DNL underperformed the UK Biotechs industry which returned -42.3% over the past year.
Rentabilidad vs. Mercado: DNL underperformed the UK Market which returned -13.8% over the past year.
Volatilidad de los precios
| DNL volatility | |
|---|---|
| DNL Average Weekly Movement | 38.5% |
| Biotechs Industry Average Movement | 7.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.7% |
Precio estable de las acciones: DNL's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: DNL's weekly volatility has increased from 21% to 39% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2015 | 33 | Richard Bungay | www.diurnal.co.uk |
Resumen de fundamentos de Diurnal Group plc
| Estadísticas fundamentales de DNL | |
|---|---|
| Capitalización bursátil | UK£47.74m |
| Beneficios(TTM) | -UK£16.57m |
| Ingresos (TTM) | UK£4.68m |
10.2x
Ratio precio-ventas (PS)-2.9x
Ratio precio-beneficio (PE)¿Está DNL sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DNL | |
|---|---|
| Ingresos | UK£4.68m |
| Coste de los ingresos | UK£1.02m |
| Beneficio bruto | UK£3.66m |
| Otros gastos | UK£20.23m |
| Beneficios | -UK£16.57m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.095 |
| Margen bruto | 78.16% |
| Margen de beneficio neto | -353.76% |
| Ratio deuda/patrimonio | 0.0% |
¿Cómo se ha desempeñado DNL a largo plazo?
Ver rendimiento histórico y comparativa